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A cross-sectional survey of tuberculin skin reactivity was conducted in Al-Ain, United Arab Emirates 
(U.A.E.) between January and June 1994, to find out the prevalence rate of tuberculosis infection. A 
pre-designed questionnaire was used to collect details of BCG scar, age, sex, residence area, nationality, 
education, type of house, number of rooms, family size and household contact history of tuberculosis. A total 
of 785 students were screened, of whom 547 gave a history of BCG vaccination in the past and 238 were 
BCG-negative. Among BCG-negative children aged 5-11 years and 12-15 years, only 6.5% and 9.3%, 
respectively, had a positive Mantoux reaction - a rate lower than most Third World countries, but higher 
than developed countries where under 2% of children are tuberculin reactors. A general linear model with 
positive Mantoux reaction as the dependent variable was fitted to the data to examine the joint effect of age, 
sex, residential area, number of rooms at home, family size and BCG vaccine history. The Mantoux reaction 
was entered as positive and a number of statistically significant associations were found between positive 
Mantoux test > 10 mm and: age (P=O.O018); sex (P=O.O281); residential area (P<O.OOOl); number of rooms 
(P=O.O017); and BCG vaccine history (P<O.OOOl). However, family size did not have any statistical effect on 
tuberculin testing (Mantoux test > 10 mm). The prevalence (8%) in the 5-14 years age group puts U.A.E. 
between low (2%) and middle (14%) prevalence countries, according to the classification of.the International 
Union Against Tuberculosis. This calls for continuation of free treatment of active cases and increased efforts 
towards screening of contacts. 
Introduction 
There has been a marked decline in morbidity and 
mortality from tuberculosis all over the world, but it 
remains a major health problem in most developing 
countries (1) and especially in neighbouring Gulf 
countries (2-7). 
The overall incidence of tuberculosis has declined 
steadily in U.A.E. specially over the past decade. 
BCG vaccination shortly after birth has been shown 
to protect against tuberculosis in many countries (8). 
The policy of the Ministry of Health in U.A.E. is to 
offer BCG vaccinations to all babies within the first 
few days of birth. However, most cases of tubercu- 
losis in U.A.E. were detected among expatriates who 
had recently arrived in the country. It is worth noting 
that the issuing of a residence visa is subject to a 
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tuberculosis clearance. All new expatriates are rou- 
tinely screened for tuberculosis as well as other 
diseases that might endanger public health as per the 
law of communicable diseases (9). An epidemio- 
logical study of tuberculosis infection in U.A.E. 
was conducted as a small pilot study in a semi-rural 
area among BCG-negative children aged O-14 years; 
only 8.3% had a positive Mantoux reaction > 10 mm 
(10). 
A World Health Organization (WHO) Expert 
Committee on tuberculosis (11) has recommended 
that the age-specific prevalence of tuberculous infec- 
tion can be assessed in a community by tuberculin 
skin survey. The WHO Expert Committee (12) also 
noted that ‘mass miniature radiography is a very 
expensive screening procedure for tuberculosis, even 
when the prevalence is high’. This recommendation 
has been reaffirmed by a joint International Union 
Against Tuberculosis (IUAT)/WHO study group on 
tuberculosis control in 1982 (13). In view of this 
recommendation, chest radiography would be un- 
necessary and inadvisable for the purpose of a sample 
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survey to determine the extent of the tuberculosis 
problem in U.A.E. 
To formulate a national tuberculosis control pro- 
gramme, it is necessary to have baseline data on the 
prevalence of the disease and its characteristics 
in various parts of the country. No country-wide 
epidemiological data on tuberculosis are available 
for U.A.E. Tuberculosis in U.A.E., like other Gulf 
countries with multi-national inhabitants, is one of 
the major public health problems (7). The aim of the 
present study is to determine the epidemiological 
prevalence rate of tuberculous infection in Al- 
Ain, U.A.E., using tuberculin test positivity, as 
recommended by WHO (1 l-l 3). 
Materials and Methods 
A cross-sectional tuberculosis survey of primary 
and secondary schools was conducted between 
January and June 1994 in Al-Ain City, U.A.E. A 
team of an experienced school physician and nurses 
were recruited and trained to achieve the study 
objectives. This included an interview using a pre- 
designed questionnaire, and Mantoux skin testing 
procedure. The study was conducted in both urban 
and rural areas of Al-Ain City, U.A.E. 
TYPE AND SIZE OF SAMPLE 
According to the few limited studies available, the 
prevalence of tuberculosis in U.A.E. vary from 8% to 
10% (7,9,10). Because of this variability, a fairly large 
sample was needed. To derive the required sample 
size, a (level of significance) was set at 0.05, and l-b 
(power) was set at 0.80. To fulfil the requirement of 
the objectives, 800 subjects were needed in order to 
be 95% confident of a true resnlt (14). The subjects 
were all aged 5-14 years. A multi-stage sampling 
technique was used and the schoolchildren were 
selected randomly. Stratification allowed both urban 
and rural areas to be proportionally represented. The 
survey was based on stratified sampling methods 
used in the WHO Expanded Programme on Immu- 
nization (EPI) (15). The questionnaires and adminis- 
tration team were the same in urban and rural areas. 
In order to have a fair representation of rural and 
urban residents in the sample, children attending 
school at their respective living areas were surveyed. 
Urban areas were those districts situated within the 
periphery of the city of Al-Ain. Rural areas were 
defined as those villages located immediately outside 
the Al-Ain City limits. Since 80% of the population 
live in urban areas, 80% of the sample size was 
allocated to the urban area and the remaining 20% to 
the rural communities. The list of names of govern- 
ment schools was obtained from the Director of 
General Education in the Ministry of Education. 
Government schools in Al-Ain are segregated 
according to the sexes. 
As recommended by WHO’s EPI (15) sampling 
method instead of making a cumulative list of village 
populations, a cumulative list of school populations 
was made. The total school population was then 
divided by the number of clusters (no. of schools) 
needed to determine the sampling interval (a). Like- 
wise, a random number (n) was selected within the 
size of sampling interval. The first school selected 
attended by the nth child; the second school selected 
was that attended by the nth+a child; the third by the 
nth+2a child etc., until eight schools were identified. 
From an attendance list, children were randomly 
selected to provide n. This process was repeated until 
all eight schools were identified. School attendance 
was obtained from the Director of Education or from 
the randomly selected headmaster of the selected 
school and from this list, a child was randomly 
chosen. The majority of U.A.E. national students are 
located in eight districts. In the first stage, one school 
from each of these eight districts was selected ran- 
domly thus overcoming the so-called ‘cluster effect’ 
that could have occurred if the schools were put into 
one pool and names were randomly selected. This 
could possibly have resulted in schools in only one 
area of the town being represented. In the rural area, 
two schools for boys and one school for girls were 
selected randomly. Similarly, the classrooms and 
schoolchildren were selected in the second and third 
stages using the same simple random sampling 
procedure that resulted in the selection of 800 
students (determined sample size) who proportion- 
ally represented the study population. 
Mantoux test was given to 800 subjects but 
analyses were based on only 785 subjects due to 
incomplete data and/or failure to be available for 
reading the test. 
QUESTIONNAIRE 
Using a pre-designed questionnaire, the following 
information was recorded: age; sex; nationality 
(U.A.E. nationals only); education (primary, or sec- 
ondary); type of house; number of rooms; and family 
size. The presence or absence of BCG scar was read 
blindly while the history of receiving BCG vacci- 
nation was confirmed after verification of the im- 
munization health card by the nurses (immunization 
health card provided by the Ministry of Health). The 
questionnaire was designed so that all information 
relevant to the objectives of this project could be 
entered in a coded form convenient for subsequent 
computer processing. The information was filled in 
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by the Research Officer or School Nurse in the school 
at the screening. 
Data on symptoms and diseases of the respiratory 
system were obtained from each subject. These 
included history of cough, sputum production, or 
fever for more than 1 month at the time of the sur- 
vey. Past history of tuberculosis, history of any 
other chronic lung disease and family history of 
tuberculosis were also recorded. 
TUBERCULIN TESTING 
The Mantoux test was performed using five tuber- 
culin units (5 TU) of the purified protein derivative 
(PPD) Tubersol Diagnostic Antigen Connaught 
(Willowdale, Canada). Using a tuberculin syringe, 
0.1 ml 5 TU was injected intradermally on the volar 
surface of the forearm. The test was read 48 h later. 
Individuals with induration measuring 10 mm or 
more were considered to have a positive reaction 
(45). A positive reaction indicates a sensitivity to 
tuberculin which may be the result of a previous 
infection with Mycobacterium tuberculosis. In- 
duration measuring 5-9 mm indicates a doubtful or 
intermediate reaction. In the phase of negative con- 
tact history with active disease, the intermediate 
reaction was considered as either previous exposure 
to environmental non-tuberculous mycobacteria or a 
reaction to earlier BCG vaccination. Induration of 
less than 5 mm was interpreted as a negative reaction 
(4,5). 
STATISTICAL ANALYSES 
The data collected was coded for computer entry 
and processed using the SAS statistical computer 
package (16). Descriptive statistics included fre- 
quency tables and cross-tabulations. The Chi-square 
test was used to investigate any trend with age, as 
well as the association between BCG history and 
both positive and negative Mantoux reaction. A 
general linear model was used to explore the joint 
effects of demographic variables. The effect of the 
various variables; such as age, sex, number of rooms, 
family size, education, and BCG vaccine history; on 
the prevalence of tuberculous infection (as measured 
by tuberculin test) was evaluated using a general 
linear model (17). Probability less or equal to 0.05 
was considered as the cut-off value for significance. 
Results 
Table 1 shows the characteristics of the population 
surveyed. Mantoux test was given to 800 individuals, 
but the statistical analyses were based on only 785 
individuals due to incomplete data for the rest; 
Table 1 Characteristics of the population surveyed 
Population 
characteristics Number Percentage 
Total number screened 
Age (years): 
5-11 
12-15 
Sex: 
Male 
Female 
Residence: 
Urban 
Rural 
Type of house: 
Villa 
Semi-villa 
Flat, Apt. 
Mud house 
Number of rooms: 
<4 
4-6 
>7 
Members of family: 
<3 
4-7 
~8 
Education: 
Primary 
Secondary 
BCG vaccine history: 
Positive 
Negative 
BCG scar: 
Present 
Absent 
785 100 
506 64.5 
279 35.5 
431 54,9 
354 45.1 
644 82 
141 18 
215 27.4 
140 17.8 
69 8.8 
361 46.0 
238 28.3 
505 64.3 
42 5.4 
151 19.2 
485 61.8 
149 19.0 
506 64.5 
279 35.5 
544 69.6 
238 30.4 
428 54.5 
357 45.5 
mainly failure to be available for reading the test. The 
‘nearly equal’ number of males (54.9%) and females 
(45.1%) reflects the success of the team to overcome 
the reluctance of conservative U.A.E. families to 
allow screening of females. Of the 785 individuals, 
69.2% had BCG-positive vaccine history and 238 
(30.1%) had BCG-negative history or their vacci- 
nation history was not known. Also, 54.5% had a 
BCG scar present and 45.5% had no BCG scar. 
The effect of age on the size of the Mantoux 
reaction in subjects with negative and positive BCG 
history is shown in Table 2. It is clear from the table 
that positive Mantoux reaction (10 mm or above) 
increased significantly with age. Previous BCG vac- 
cination increased the incidence of positive reactions, 
decreased the incidence of negative reactions, but 
had no effect on intermediate reactions (5-9 mm). 
Positive Mantoux reaction was significantly higher 
among BCG-positive subjects in all age groups. A 
Chi-square test for trends shows a significant 
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Table 2 Effect of age on the size of Mantoux reaction in subjects with negative and positive 
BCG histories 
Age (years) 5-11 12-14 Total 
Mantoux test 
(mm) BCG history No. (%) No. (“Yo) No. (%) 
CL4 Negative 96/109 (88) 991129 (76.7) 195/238 (82) PCO.04 
o-4 Positive 322/397 (81) 109/147 (74.1) 431/544 (79.2) n.s. 
5-9 Negative 6/109 (55) 18/129 (14.0) 24/238 (10) PCO.05 
5-9 Positive 41/397 (10.4) 9/147 (6.1) 50/544 (9.1) n.s. 
lO> Negative 7/109 (6.5) 12/129 (9.3) 19/238 (8) n.s. 
lO> Positive 34/397 (8.6) 29/147 (19.7) 63/544 (11.6) P<O.Ol 
BCG-negative 5-9 mm vs. BCG-positive 5-9 mm, Chi-square=20.34, d.f.= 1, P<O.OOOl. 
BCG-negative> 10 mm vs. BCG-positive >lO mm, Chi-square= 1.10, d.f.= 1, P=O.295. 
Tuble 3 General linear model with positive Mantoux test > 10 mm reaction was fitted to the 
data to examine joint effects of demographic explanatory variables 
Explanatory Regression 
variables coefficient 
Standard 
error 
t-statistics 
test P-value 
Age 0.506 0.161 3.125 0.0018 
Sex 0336 0.153 2.200 0.0281 
No. rooms - 0.361 0.114 - 3.157 0.0017 
Residence 0.777 0.193 4.013 0~0001 
BCG vaccine history - 0.733 0.191 - 3.831 0~0001 
Family size 0.030 0.062 0.0489 0.6253 
increase of positive Mantoux reaction with increasing 
age among subjects with both negative and positive 
BCG history (BCG-negative Mantoux 5-9 mm and 
BCG-positive Mantoux 10 mm). 
A general linear model with positive Mantoux 
reaction as the dependent variable was fitted to the 
data to examine the joint effect of age, sex, residential 
area, number of rooms at home, family size or 
number of members at home, and BCG vaccine 
history. Table 3 shows data for positive Mantoux 
reactions. A number of statistically significant 
associations were found between positive Mantoux 
test >lOmm and: age (P=O.O018); sex (P=O.O281); 
residential area (P<O.OOOl); number of rooms 
(P=O.O017); and BCG vaccine history (P<O.OOOl). 
However, family size did not have any statisti- 
cal effect on tuberculin testing (Mantoux test 
> 10 mm). 
There was no significant effect of clinical history, 
presence of cough, chest problems or symptoms 
described in the WHO methods on the prevalence of 
positive Mantoux test. 
Discussion 
The rise of tuberculosis prevalence with age is 
similar to findings in other countries (4,5,18-25) and 
represents increased and cumulative exposure in 
older subjects as well as reduced contact with open 
tuberculosis cases for those subjects born in the last 
15 yr (Table 4). As per the classification proposed by 
the IUAT (18), it is clear than in terms of exposure to 
risk of infection (with or without disease), the 8% 
prevalence rate in 5-14-year-olds in Al-Ain, U.A.E., 
ranks U.A.E. midway between low (2%) and middle 
(14%) prevalence countries. The rise of tuberculosis 
prevalence with age is similar to findings in other 
neighbouring Gulf countries (4-6) (Table 4). Urban 
areas have a higher prevalence of positive Mantoux 
test than rural areas. This could be explained by the 
fact that in Al-Ain, U.A.E., people in urban areas are 
more likely than those in rural areas to come into 
contact with thousands of people visiting regularly 
from different parts of the U.A.E. and other parts of 
the world. 
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Table 4 Prevalence of infection in children in various countries compared with the classifica- 
tion of the International Union Against Tuberculosis 
Study As Prevalence of 
Country Reference period (years) infection (%) 
Saudi Arabia 4 1990 5-14 4 
Saudi Arabia 5 1991 5-14 5 
Bahrain I 1991 5-14 6.8 
India - rural 19 1968 5-14 15.4 
South Africa - Black 20 1974 lo-14 21.4 
Norway 21 1970 5-14 1 
Gambia - rural 22 1985 <lo 20 
Northern Lebanon 23 1980 7-17 4 
U.S.A. 24 1973 5-14 1 
Edinburgh 25 1986 5-14 8 
The prevalence of tuberculosis in the 5-14 years References 
age group was 8%, which places U.A.E. midway 
between low (2%) and middle (14%) prevalence 
countries (18). This reflects diminished exposure 
of children to open cases of tuberculosis in the 
community. 
The results also indicate the current practice of 
giving BCG vaccination in U.A.E. in the first few 
days after birth. The WHO Expert Committee on 
Tuberculosis (11) recommends this should be contin- 
ued until the percentage of tuberculin reactors at 
school-entering age drops to 2%. Presently, the 
prevalence rate of 6.5% in age group 5-l 1 years rises 
to 9.3% in age group 11-14 years. Second vaccination 
should also be given at school-leaving age. The WHO 
Expert Committee on Tuberculosis recommends that 
revaccination would be necessary in countries with 
high transmission. 
However, the current policy of screening all foreign 
labour within 4 weeks of entering U.A.E. for active 
tuberculosis, should continue until the nationwide 
survey is completed. We strongly recommend the 
continuation of these measures in U.A.E. Finally, we 
recommend that a similar study should be done in 
about 5 yr from now in order to make comparisons 
with these findings and determine the prevailing 
trends or changes. 
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